800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredNo results found!
Opioid treatment in the Bronx: a borough hit hardest, and a dense network of help
The Bronx carries the highest rate of fatal overdose of any New York City borough, more than double Manhattan’s, even after a real decline in 2024. It also holds one of the densest concentrations of medication treatment in the country: opioid treatment programs (OTPs), hospital-based clinics at systems like BronxCare and Montefiore, office-based prescribers, and statewide telehealth. The listings above show specific providers near you. The rest of this page is local context on what those listings mean, how to pay, and how to start, whether you are seeking care for yourself or for someone you love.
Why the Bronx gets its own overdose-prevention focus
Overdose deaths across New York City fell from 3,056 in 2023 to 2,192 in 2024, a 28% drop and the largest single-year decline the city has recorded, according to the NYC Department of Health and Mental Hygiene (DOHMH, 2025). Bronx residents saw a 24% decrease, yet the borough still had the highest overdose death rate citywide, and residents of Hunts Point-Mott Haven, Highbridge-Morrisania, Crotona-Tremont, and Fordham-Bronx Park bore the greatest burden (DOHMH, 2025). Fentanyl was involved in 73% of citywide overdose deaths, and xylazine, a sedative that naloxone does not reverse, appeared in 21% (DOHMH, 2025). These numbers describe real loss, and they are also why the help here is concentrated: effective medication treatment exists across the borough, and the next section explains how to reach it.
Harm reduction and naloxone close to home
Naloxone, the medication that reverses an opioid overdose, is available over the counter and through pharmacies and community programs. In the Bronx, harm-reduction groups distribute naloxone and train people to use it; St. Ann’s Corner of Harm Reduction in the South Bronx runs syringe services and overdose-response training. New York’s overdose prevention centers, the first government-sanctioned sites in the country, currently operate in East Harlem and Washington Heights rather than the Bronx, but their teams do outreach in the borough. Because the local supply often contains xylazine, carrying naloxone still matters even though it works only on the opioid part of a mix. A return to use is a common, manageable part of recovery, not a failure, and keeping naloxone on hand is a practical safeguard while you or someone you care about is getting established in treatment.
Your medication options and where the Bronx provides them
Three FDA-approved medications treat opioid use disorder, and the setting depends on which one you and a clinician choose. Methadone for opioid use disorder is provided only through licensed opioid treatment programs, not regular pharmacies. Buprenorphine, including Suboxone and other buprenorphine-naloxone products, can be prescribed in a doctor’s office, a hospital clinic, or an OTP, and filled at a pharmacy; an extended-release injection (Sublocade) is given monthly. Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but it starts only after you have been off opioids for a set time. If you are unsure which fits, it helps to see how methadone and Suboxone compare and to read more background on methadone before you call. The choice is yours to make with a clinician; this page does not steer you toward any one option.
Starting treatment after fentanyl
Intake usually begins with an assessment of your history and a conversation about which medication fits. Because most of the Bronx drug supply is fentanyl, the timing of a first buprenorphine dose matters: starting Suboxone too soon after using can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician plans the first dose with you. Starting methadone when you have been using fentanyl works differently and is managed inside an OTP. New York’s MATTERS network was built to move people from an emergency department or other front door into outpatient buprenorphine within days, and the OASAS HOPEline (1-877-846-7369) is staffed around the clock if you want help finding a starting point. Same-day starts exist at some programs; the listings above are where to call to ask about today.
Take-home doses, telehealth, and the current rules
Federal rules updated by SAMHSA in 2024 expanded take-home methadone (up to a 28-day supply for patients who are stable in treatment), allowed treatment to start by telehealth, and removed the older requirement of a year of opioid addiction before OTP admission. Take-home eligibility is decided by the program based on clinical stability. As of June 2026, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit; those flexibilities run through 2026 and are still being finalized, so confirm what is current with a provider. Methadone for opioid use disorder is still started and dispensed through an OTP, though some programs can begin treatment with a telehealth visit, and OASAS-regulated mobile medication units now extend OTP dosing into areas farther from a brick-and-mortar clinic. If you are transferring care or returning after a gap, long-term medication treatment is legitimate care, and staying at a steady dose protects the progress you have made.
Paying for care in the Bronx
New York Medicaid covers all three FDA-approved medications for opioid use disorder, including methadone in OTPs, buprenorphine through the NYRx pharmacy benefit, and naltrexone. New York insurance law also prohibits prior authorization for substance use disorder medications, which removes one common delay. OTP services in New York are exempt from Medicaid’s Recipient Restriction Program, so a member restricted to a single provider can still receive methadone or buprenorphine at an OTP. Most private plans sold in the state cover buprenorphine and naltrexone; methadone coverage in commercial plans is less consistent and worth confirming with the clinic. Many OASAS-certified programs offer sliding-scale fees or accept the state’s substance use disorder block grant if you are uninsured.
Pregnancy, reentry, and other specific situations
For pregnant patients, medication for opioid use disorder is the recommended standard of care; OASAS, SAMHSA, and ACOG advise methadone or buprenorphine over withdrawal, because medication is linked to better outcomes for both parent and newborn. A clinician can also explain neonatal opioid withdrawal syndrome (NOWS) and how it is managed. Fear of child-welfare involvement keeps some people from seeking care, so it helps to know that New York’s Plan of Safe Care framework is designed to support the family, and treatment is the protective step. The Bronx also sees many people entering treatment from Rikers Island or returning home after incarceration; New York’s MATTERS network now reaches correctional settings to keep buprenorphine going through release. More on methadone and pregnancy and guidance for families can help you prepare for that first call.
Common questions from Bronx readers
Do I have to go to a clinic every day?
Not necessarily. Methadone starts with more frequent visits, but under the 2024 federal rules a program can approve take-home doses, up to a 28-day supply, once you are stable (DOHMH and SAMHSA). Buprenorphine and naltrexone are often managed with office visits and a pharmacy pickup rather than daily attendance.
Can I start buprenorphine without coming in first?
Often yes. As of June 2026, buprenorphine can be started by telehealth, including by phone in many cases, without a prior in-person visit. The rule is still being finalized, so a provider can tell you what applies the day you call.
Is methadone available at a pharmacy?
No. Methadone for opioid use disorder is dispensed only through a licensed opioid treatment program, not a retail pharmacy. Buprenorphine and naltrexone can be filled at a pharmacy.
What is the difference between methadone and Suboxone?
Both reduce cravings and withdrawal. Methadone is a full agonist dispensed through an OTP; buprenorphine, the active medication in Suboxone, is a partial agonist that can be prescribed in an office. A fuller side-by-side comparison can help you decide with a clinician.
How long will I be on medication?
There is no set timeline. Many people do best staying on methadone or buprenorphine for years; others taper later under supervision. How treatment ends is a decision you make with your provider, not a deadline.
Last reviewed June 2026.
Sources:NYC DOHMH, Unintentional Drug Poisoning (Overdose) Deaths in NYC in 2024, Epi Data Brief No. 150 (2025); NYC Mayor’s Office overdose data announcement (2025); SAMHSA, Medications for Opioid Use Disorder and the 2024 revision of 42 CFR Part 8; Federal Register, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (2026) and DEA buprenorphine telemedicine final rule (effective December 31, 2025); New York State Office of Addiction Services and Supports (OASAS), Medications for the Treatment of Opioid Use Disorder; New York State MATTERS network.
Methadone Centers is a treatment-discovery and education resource, not a treatment provider, and does not give medical advice. Some calls to numbers on this site may be answered by a sponsored treatment provider; this does not influence which providers appear in the directory.